SSY Group Limited — Board/Management Information 2012

Dec 18, 2012

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [308 x 113] intentionally omitted <==

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2005)

RESIGNATION OF EXECUTIVE DIRECTORS AND CHANGE OF AUTHORIZED REPRESENTATIVE

To promote corporate governance among listed issuers, The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) has introduced a series of amendments to the Corporate Governance Code and the Rules Governing the Listing of Securities on the Stock Exchange (the “Listing Rules”). As part of these amendments, a new Rule 3.10A was introduced where independent non-executive directors of a listed issuer must represent at least one-third of the board by 31 December 2012.

The board of directors (the “Board”) of Lijun International Pharmaceutical (Holding) Co., Ltd. (the “Company”) announces the following changes:

RESIGNATION OF EXECUTIVE DIRECTORS

In order to comply with the new requirements of Rule 3.10A of the Listing Rules, Mr. Huang Chao, Mr. Bao Leyuan and Ms. Gao Shuping (the “resigned directors”) have voluntarily resigned as executive directors of the Company with effect from 17 December 2012. Following their resignation, the Board will have five executive directors and three independent non-executive directors and will be in compliance with the new requirements of Rule 3.10A of the Listing Rules.

The resigned directors have confirmed that they have no disagreement with the Board and there are no matters that need to be brought to the attention of the Stock Exchange or/and the shareholders of the Company in relation to their resignation.

CHANGE OF AUTHORIZED REPRESENTATIVE

The Board also announces that Mr. Bao Leyuan has voluntarily resigned as Authorized Representative of the Company and Mr. Xie Yunfeng, an executive director, has been appointed as Authorized Representative of the Company, in each case with effect from 17 December 2012.

— 1 —

The Board would like to take this opportunity to express its appreciation to Mr. Huang Chao, Mr. Bao Leyuan and Ms. Gao Shuping for their valuable contribution to the Company during their tenure of offices as executive directors of the Company.

By order of the Board Chow Hing Yeung Company Secretary

Hong Kong, 18 April 2012

As at the date of this announcement, the Board comprises Mr. Wu Qin, Mr. Qu Jiguang, Mr. Xie Yunfeng, Mr. Wang Xianjun and Mr. Duan Wei as executive Directors, and Mr. Wang Yibing, Mr. Leung Chong Shun and Mr. Chow Kwok Wai as independent non-executive Directors.

— 2 —